-
1
-
-
77951755278
-
Pancreatic cancer
-
Hidalgo M. Pancreatic cancer. N Engl J Med. 2010; 362(17):1605-1617.
-
(2010)
N Engl J Med.
, vol.362
, Issue.17
, pp. 1605-1617
-
-
Hidalgo, M.1
-
2
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD and Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell. 2012; 148(1-2):349-361.
-
(2012)
Cell.
, vol.148
, Issue.1-2
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
Maitra, A.4
Bailey, J.M.5
McAllister, F.6
Reichert, M.7
Beatty, G.L.8
Rustgi, A.K.9
Vonderheide, R.H.10
Leach, S.D.11
Stanger, B.Z.12
-
3
-
-
34848854859
-
Causes of death in patients with unresectable hepatocellular carcinoma
-
Couto OF, Dvorchik I and Carr BI. Causes of death in patients with unresectable hepatocellular carcinoma. Digestive diseases and sciences. 2007; 52(11):3285-3289.
-
(2007)
Digestive diseases and sciences.
, vol.52
, Issue.11
, pp. 3285-3289
-
-
Couto, O.F.1
Dvorchik, I.2
Carr, B.I.3
-
4
-
-
47949116252
-
Sorafenib in advanced hepatocellular carcinoma
-
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-390.
-
(2008)
N Engl J Med.
, vol.359
, Issue.4
, pp. 378-390
-
-
Llovet, J.M.1
Ricci, S.2
Mazzaferro, V.3
Hilgard, P.4
Gane, E.5
Blanc, J.F.6
de Oliveira, A.C.7
Santoro, A.8
Raoul, J.L.9
Forner, A.10
Schwartz, M.11
Porta, C.12
Zeuzem, S.13
Bolondi, L.14
Greten, T.F.15
Galle, P.R.16
-
7
-
-
35148883003
-
Tgf-Beta signaling in development
-
Kitisin K, Saha T, Blake T, Golestaneh N, Deng M, Kim C, Tang Y, Shetty K, Mishra B and Mishra L. Tgf-Beta signaling in development. Science's STKE: signal transduction knowledge environment. 2007; 2007(399):cm1.
-
(2007)
Science's STKE: signal transduction knowledge environment
, vol.2007
, Issue.399
-
-
Kitisin, K.1
Saha, T.2
Blake, T.3
Golestaneh, N.4
Deng, M.5
Kim, C.6
Tang, Y.7
Shetty, K.8
Mishra, B.9
Mishra, L.10
-
8
-
-
79952706985
-
Transforming growth factor-beta and the hallmarks of cancer
-
Tian M, Neil JR and Schiemann WP. Transforming growth factor-beta and the hallmarks of cancer. Cellular signalling. 2011; 23(6):951-962.
-
(2011)
Cellular signalling.
, vol.23
, Issue.6
, pp. 951-962
-
-
Tian, M.1
Neil, J.R.2
Schiemann, W.P.3
-
9
-
-
33845524970
-
Transforming growth factor-beta in cancer and metastasis
-
Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev. 2006; 25(3):435-457.
-
(2006)
Cancer Metastasis Rev.
, vol.25
, Issue.3
, pp. 435-457
-
-
Jakowlew, S.B.1
-
10
-
-
84867992286
-
TGF-beta signalling and its role in cancer progression and metastasis
-
Drabsch Y and ten Dijke P. TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 2012; 31(3-4):553-568.
-
(2012)
Cancer Metastasis Rev.
, vol.31
, Issue.3-4
, pp. 553-568
-
-
Drabsch, Y.1
ten Dijke, P.2
-
11
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008; 321(5897):1801-1806.
-
(2008)
Science.
, vol.321
, Issue.5897
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
Lin, J.C.4
Leary, R.J.5
Angenendt, P.6
Mankoo, P.7
Carter, H.8
Kamiyama, H.9
Jimeno, A.10
Hong, S.M.11
Fu, B.12
Lin, M.T.13
Calhoun, E.S.14
Kamiyama, M.15
Walter, K.16
-
12
-
-
0026406073
-
Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma
-
Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M and Tarui S. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer research. 1991; 51(15):4080-4083.
-
(1991)
Cancer research.
, vol.51
, Issue.15
, pp. 4080-4083
-
-
Ito, N.1
Kawata, S.2
Tamura, S.3
Takaishi, K.4
Shirai, Y.5
Kiso, S.6
Yabuuchi, I.7
Matsuda, Y.8
Nishioka, M.9
Tarui, S.10
-
13
-
-
0028301747
-
Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases
-
Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, Kiso S and Matsuzawa Y. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer. 1994; 73(9):2275-2279.
-
(1994)
Cancer.
, vol.73
, Issue.9
, pp. 2275-2279
-
-
Shirai, Y.1
Kawata, S.2
Tamura, S.3
Ito, N.4
Tsushima, H.5
Takaishi, K.6
Kiso, S.7
Matsuzawa, Y.8
-
14
-
-
0028959114
-
Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers
-
Bedossa P, Peltier E, Terris B, Franco D and Poynard T. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 1995; 21(3):760-766.
-
(1995)
Hepatology.
, vol.21
, Issue.3
, pp. 760-766
-
-
Bedossa, P.1
Peltier, E.2
Terris, B.3
Franco, D.4
Poynard, T.5
-
15
-
-
79251633236
-
Inhibiting TGF-beta signaling in hepatocellular carcinoma
-
Giannelli G, Mazzocca A, Fransvea E, Lahn M and Antonaci S. Inhibiting TGF-beta signaling in hepatocellular carcinoma. Biochimica et biophysica acta. 2011; 1815(2):214-223.
-
(2011)
Biochimica et biophysica acta.
, vol.1815
, Issue.2
, pp. 214-223
-
-
Giannelli, G.1
Mazzocca, A.2
Fransvea, E.3
Lahn, M.4
Antonaci, S.5
-
16
-
-
0036317838
-
Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin
-
Giannelli G, Fransvea E, Marinosci F, Bergamini C, Colucci S, Schiraldi O and Antonaci S. Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin. Am J Pathol. 2002; 161(1):183-193.
-
(2002)
Am J Pathol.
, vol.161
, Issue.1
, pp. 183-193
-
-
Giannelli, G.1
Fransvea, E.2
Marinosci, F.3
Bergamini, C.4
Colucci, S.5
Schiraldi, O.6
Antonaci, S.7
-
17
-
-
27744527762
-
Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
-
Giannelli G, Bergamini C, Fransvea E, Sgarra C and Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology. 2005; 129(5):1375-1383.
-
(2005)
Gastroenterology.
, vol.129
, Issue.5
, pp. 1375-1383
-
-
Giannelli, G.1
Bergamini, C.2
Fransvea, E.3
Sgarra, C.4
Antonaci, S.5
-
18
-
-
84862798754
-
Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma
-
Lee D, Chung YH, Kim JA, Lee YS, Lee D, Jang MK, Kim KM, Lim YS, Lee HC and Lee YS. Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma. Oncology. 2012; 82(1):11-18.
-
(2012)
Oncology.
, vol.82
, Issue.1
, pp. 11-18
-
-
Lee, D.1
Chung, Y.H.2
Kim, J.A.3
Lee, Y.S.4
Lee, D.5
Jang, M.K.6
Kim, K.M.7
Lim, Y.S.8
Lee, H.C.9
Lee, Y.S.10
-
19
-
-
26244433508
-
The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma
-
Ikeguchi M, Iwamoto A, Taniguchi K, Katano K and Hirooka Y. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. J Exp Clin Cancer Res. 2005; 24(3):415-421.
-
(2005)
J Exp Clin Cancer Res.
, vol.24
, Issue.3
, pp. 415-421
-
-
Ikeguchi, M.1
Iwamoto, A.2
Taniguchi, K.3
Katano, K.4
Hirooka, Y.5
-
20
-
-
0031595728
-
Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival
-
Coppola D, Lu L, Fruehauf JP, Kyshtoobayeva A, Karl RC, Nicosia SV and Yeatman TJ. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival. American journal of clinical pathology. 1998; 110(1):16-23.
-
(1998)
American journal of clinical pathology.
, vol.110
, Issue.1
, pp. 16-23
-
-
Coppola, D.1
Lu, L.2
Fruehauf, J.P.3
Kyshtoobayeva, A.4
Karl, R.C.5
Nicosia, S.V.6
Yeatman, T.J.7
-
21
-
-
0034744458
-
Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas
-
Hashimoto K, Nio Y, Sumi S, Toga T, Omori H, Itakura M and Yano S. Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas. Pancreas. 2001; 22(4):341-347.
-
(2001)
Pancreas.
, vol.22
, Issue.4
, pp. 341-347
-
-
Hashimoto, K.1
Nio, Y.2
Sumi, S.3
Toga, T.4
Omori, H.5
Itakura, M.6
Yano, S.7
-
22
-
-
0027131252
-
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival
-
Friess H, Yamanaka Y, Buchler M, Ebert M, Beger HG, Gold LI and Korc M. Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology. 1993; 105(6):1846-1856.
-
(1993)
Gastroenterology.
, vol.105
, Issue.6
, pp. 1846-1856
-
-
Friess, H.1
Yamanaka, Y.2
Buchler, M.3
Ebert, M.4
Beger, H.G.5
Gold, L.I.6
Korc, M.7
-
23
-
-
26844446396
-
Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics
-
Culhaci N, Sagol O, Karademir S, Astarcioglu H, Astarcioglu I, Soyturk M, Oztop I and Obuz F. Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer. 2005; 5:98.
-
(2005)
BMC Cancer.
, vol.5
, pp. 98
-
-
Culhaci, N.1
Sagol, O.2
Karademir, S.3
Astarcioglu, H.4
Astarcioglu, I.5
Soyturk, M.6
Oztop, I.7
Obuz, F.8
-
24
-
-
0032968104
-
Gene mutation of transforming growth factor beta1 type II receptor in hepatocellular carcinoma
-
Furuta K, Misao S, Takahashi K, Tagaya T, Fukuzawa Y, Ishikawa T, Yoshioka K and Kakumu S. Gene mutation of transforming growth factor beta1 type II receptor in hepatocellular carcinoma. Int J Cancer. 1999; 81(6):851-853.
-
(1999)
Int J Cancer.
, vol.81
, Issue.6
, pp. 851-853
-
-
Furuta, K.1
Misao, S.2
Takahashi, K.3
Tagaya, T.4
Fukuzawa, Y.5
Ishikawa, T.6
Yoshioka, K.7
Kakumu, S.8
-
25
-
-
0032404111
-
Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas
-
Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH and Kern SE. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res. 1998; 58(23):5329-5332.
-
(1998)
Cancer Res.
, vol.58
, Issue.23
, pp. 5329-5332
-
-
Goggins, M.1
Shekher, M.2
Turnacioglu, K.3
Yeo, C.J.4
Hruban, R.H.5
Kern, S.E.6
-
26
-
-
77956100350
-
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis
-
Mamiya T, Yamazaki K, Masugi Y, Mori T, Effendi K, Du W, Hibi T, Tanabe M, Ueda M, Takayama T and Sakamoto M. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Laboratory investigation; a journal of technical methods and pathology. 2010; 90(9):1339-1345.
-
(2010)
Laboratory investigation; a journal of technical methods and pathology.
, vol.90
, Issue.9
, pp. 1339-1345
-
-
Mamiya, T.1
Yamazaki, K.2
Masugi, Y.3
Mori, T.4
Effendi, K.5
Du, W.6
Hibi, T.7
Tanabe, M.8
Ueda, M.9
Takayama, T.10
Sakamoto, M.11
-
27
-
-
0032711157
-
Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer
-
Wagner M, Kleeff J, Friess H, Buchler MW and Korc M. Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. Pancreas. 1999; 19(4):370-376.
-
(1999)
Pancreas.
, vol.19
, Issue.4
, pp. 370-376
-
-
Wagner, M.1
Kleeff, J.2
Friess, H.3
Buchler, M.W.4
Korc, M.5
-
28
-
-
65449159717
-
Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B
-
Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K and Okazaki K. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology. 2009; 49(4):1203-1217.
-
(2009)
Hepatology.
, vol.49
, Issue.4
, pp. 1203-1217
-
-
Murata, M.1
Matsuzaki, K.2
Yoshida, K.3
Sekimoto, G.4
Tahashi, Y.5
Mori, S.6
Uemura, Y.7
Sakaida, N.8
Fujisawa, J.9
Seki, T.10
Kobayashi, K.11
Yokote, K.12
Koike, K.13
Okazaki, K.14
-
29
-
-
34347232205
-
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma
-
Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K and Seki T. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology. 2007; 46(1):48-57.
-
(2007)
Hepatology.
, vol.46
, Issue.1
, pp. 48-57
-
-
Matsuzaki, K.1
Murata, M.2
Yoshida, K.3
Sekimoto, G.4
Uemura, Y.5
Sakaida, N.6
Kaibori, M.7
Kamiyama, Y.8
Nishizawa, M.9
Fujisawa, J.10
Okazaki, K.11
Seki, T.12
-
30
-
-
57449111916
-
Genetic and epigenetic alterations of familial pancreatic cancers
-
Brune K, Hong SM, Li A, Yachida S, Abe T, Griffith M, Yang D, Omura N, Eshleman J, Canto M, Schulick R, Klein AP, Hruban RH, Iacobuzio-Donohue C and Goggins M. Genetic and epigenetic alterations of familial pancreatic cancers. Cancer epidemiology, biomarkers&prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2008; 17(12):3536-3542.
-
(2008)
Cancer epidemiology, biomarkers&prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
, vol.17
, Issue.12
, pp. 3536-3542
-
-
Brune, K.1
Hong, S.M.2
Li, A.3
Yachida, S.4
Abe, T.5
Griffith, M.6
Yang, D.7
Omura, N.8
Eshleman, J.9
Canto, M.10
Schulick, R.11
Klein, A.P.12
Hruban, R.H.13
Iacobuzio-Donohue, C.14
Goggins, M.15
-
31
-
-
0030593038
-
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
-
(New York, NY).
-
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (New York, NY). 1996; 271(5247):350-353.
-
(1996)
Science
, vol.271
, Issue.5247
, pp. 350-353
-
-
Hahn, S.A.1
Schutte, M.2
Hoque, A.T.3
Moskaluk, C.A.4
da Costa, L.T.5
Rozenblum, E.6
Weinstein, C.L.7
Fischer, A.8
Yeo, C.J.9
Hruban, R.H.10
Kern, S.E.11
-
32
-
-
84878115447
-
Targeting the Ras-ERK pathway in pancreatic adenocarcinoma
-
Neuzillet C, Hammel P, Tijeras-Raballand A, Couvelard A and Raymond E. Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Cancer Metastasis Rev. 2013; 32(1-2):147-162.
-
(2013)
Cancer Metastasis Rev.
, vol.32
, Issue.1-2
, pp. 147-162
-
-
Neuzillet, C.1
Hammel, P.2
Tijeras-Raballand, A.3
Couvelard, A.4
Raymond, E.5
-
33
-
-
68049115773
-
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer
-
Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, et al. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009; 15(14):4674-4679.
-
(2009)
Clinical cancer research: an official journal of the American Association for Cancer Research.
, vol.15
, Issue.14
, pp. 4674-4679
-
-
Blackford, A.1
Serrano, O.K.2
Wolfgang, C.L.3
Parmigiani, G.4
Jones, S.5
Zhang, X.6
Parsons, D.W.7
Lin, J.C.8
Leary, R.J.9
Eshleman, J.R.10
Goggins, M.11
Jaffee, E.M.12
Iacobuzio-Donahue, C.A.13
Maitra, A.14
Cameron, J.L.15
Olino, K.16
-
34
-
-
84863542976
-
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
-
Bachet JB, Marechal R, Demetter P, Bonnetain F, Couvelard A, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Rougier P, Penna C, Vaillant JC, Andre T, Closset J, et al. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma. Ann Oncol. 2012; 23(9):2327-2335.
-
(2012)
Ann Oncol.
, vol.23
, Issue.9
, pp. 2327-2335
-
-
Bachet, J.B.1
Marechal, R.2
Demetter, P.3
Bonnetain, F.4
Couvelard, A.5
Svrcek, M.6
Bardier-Dupas, A.7
Hammel, P.8
Sauvanet, A.9
Louvet, C.10
Paye, F.11
Rougier, P.12
Penna, C.13
Vaillant, J.C.14
Andre, T.15
Closset, J.16
-
35
-
-
84873046105
-
Smad4 expression in hepatocellular carcinoma differs by hepatitis status
-
Yao L, Li FJ, Tang ZQ, Gao S and Wu QQ. Smad4 expression in hepatocellular carcinoma differs by hepatitis status. Asian Pacific journal of cancer prevention: APJCP. 2012; 13(4):1297-1303.
-
(2012)
Asian Pacific journal of cancer prevention: APJCP.
, vol.13
, Issue.4
, pp. 1297-1303
-
-
Yao, L.1
Li, F.J.2
Tang, Z.Q.3
Gao, S.4
Wu, Q.Q.5
-
36
-
-
0036742790
-
Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling
-
Torbenson M, Marinopoulos S, Dang DT, Choti M, Ashfaq R, Maitra A, Boitnott J and Wilentz RE. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling. Human pathology. 2002; 33(9):871-876.
-
(2002)
Human pathology.
, vol.33
, Issue.9
, pp. 871-876
-
-
Torbenson, M.1
Marinopoulos, S.2
Dang, D.T.3
Choti, M.4
Ashfaq, R.5
Maitra, A.6
Boitnott, J.7
Wilentz, R.E.8
-
37
-
-
70350381535
-
Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma
-
Hiwatashi K, Ueno S, Sakoda M, Kubo F, Tateno T, Kurahara H, Mataki Y, Maemura K, Ishigami S, Shinchi H and Natsugoe S. Strong Smad4 expression correlates with poor prognosis after surgery in patients with hepatocellular carcinoma. Ann Surg Oncol. 2009; 16(11):3176-3182.
-
(2009)
Ann Surg Oncol.
, vol.16
, Issue.11
, pp. 3176-3182
-
-
Hiwatashi, K.1
Ueno, S.2
Sakoda, M.3
Kubo, F.4
Tateno, T.5
Kurahara, H.6
Mataki, Y.7
Maemura, K.8
Ishigami, S.9
Shinchi, H.10
Natsugoe, S.11
-
38
-
-
62149136344
-
Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer
-
Wang P, Fan J, Chen Z, Meng ZQ, Luo JM, Lin JH, Zhou ZH, Chen H, Wang K, Xu ZD and Liu LM. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer. Ann Surg Oncol. 2009; 16(4):826-835.
-
(2009)
Ann Surg Oncol.
, vol.16
, Issue.4
, pp. 826-835
-
-
Wang, P.1
Fan, J.2
Chen, Z.3
Meng, Z.Q.4
Luo, J.M.5
Lin, J.H.6
Zhou, Z.H.7
Chen, H.8
Wang, K.9
Xu, Z.D.10
Liu, L.M.11
-
39
-
-
84881028557
-
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
-
Xia H, Ooi LL and Hui KM. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology. 2013; 58(2):629-641.
-
(2013)
Hepatology.
, vol.58
, Issue.2
, pp. 629-641
-
-
Xia, H.1
Ooi, L.L.2
Hui, K.M.3
-
40
-
-
33751251034
-
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
-
Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D and DePinho RA. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes&development. 2006; 20(22):3130-3146.
-
(2006)
Genes&development.
, vol.20
, Issue.22
, pp. 3130-3146
-
-
Bardeesy, N.1
Cheng, K.H.2
Berger, J.H.3
Chu, G.C.4
Pahler, J.5
Olson, P.6
Hezel, A.F.7
Horner, J.8
Lauwers, G.Y.9
Hanahan, D.10
DePinho, R.A.11
-
41
-
-
0034032009
-
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression
-
Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE and Hruban RH. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 2000; 60(7):2002-2006.
-
(2000)
Cancer Res.
, vol.60
, Issue.7
, pp. 2002-2006
-
-
Wilentz, R.E.1
Iacobuzio-Donahue, C.A.2
Argani, P.3
McCarthy, D.M.4
Parsons, J.L.5
Yeo, C.J.6
Kern, S.E.7
Hruban, R.H.8
-
42
-
-
77957150824
-
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
-
Morris JPt, Wang SC and Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 2010; 10(10):683-695.
-
(2010)
Nat Rev Cancer.
, vol.10
, Issue.10
, pp. 683-695
-
-
Morris, J.P.T.1
Wang, S.C.2
Hebrok, M.3
-
43
-
-
33847387472
-
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas
-
Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, Grady WM, Deng CX, Hruban RH, Adsay NV, Tuveson DA and Hingorani SR. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell. 2007; 11(3):229-243.
-
(2007)
Cancer Cell.
, vol.11
, Issue.3
, pp. 229-243
-
-
Izeradjene, K.1
Combs, C.2
Best, M.3
Gopinathan, A.4
Wagner, A.5
Grady, W.M.6
Deng, C.X.7
Hruban, R.H.8
Adsay, N.V.9
Tuveson, D.A.10
Hingorani, S.R.11
-
44
-
-
34548550427
-
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia
-
Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, Schoeb TR, Grizzle WE and Klug CA. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res. 2007; 67(17):8121-8130.
-
(2007)
Cancer Res.
, vol.67
, Issue.17
, pp. 8121-8130
-
-
Kojima, K.1
Vickers, S.M.2
Adsay, N.V.3
Jhala, N.C.4
Kim, H.G.5
Schoeb, T.R.6
Grizzle, W.E.7
Klug, C.A.8
-
45
-
-
77249140520
-
Antimetastatic role of Smad4 signaling in colorectal cancer
-
e961-963
-
Zhang B, Halder SK, Kashikar ND, Cho YJ, Datta A, Gorden DL and Datta PK. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology. 2010; 138(3):969-980 e961-963.
-
(2010)
Gastroenterology
, vol.138
, Issue.3
, pp. 969-980
-
-
Zhang, B.1
Halder, S.K.2
Kashikar, N.D.3
Cho, Y.J.4
Datta, A.5
Gorden, D.L.6
Datta, P.K.7
-
46
-
-
46249085489
-
Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
-
(Baltimore, Md).
-
Coulouarn C, Factor VM and Thorgeirsson SS. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology (Baltimore, Md). 2008; 47(6):2059-2067.
-
(2008)
Hepatology
, vol.47
, Issue.6
, pp. 2059-2067
-
-
Coulouarn, C.1
Factor, V.M.2
Thorgeirsson, S.S.3
-
47
-
-
84877955035
-
TGF-beta signaling is often attenuated during Hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells
-
Mu X, Lin S, Yang J, Chen C, Chen Y, Herzig MC, Washburn K, Halff GA, Walter CA, Sun B and Sun LZ. TGF-beta signaling is often attenuated during Hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells. PLoS One. 2013; 8(5):e63436.
-
(2013)
PLoS One.
, vol.8
, Issue.5
-
-
Mu, X.1
Lin, S.2
Yang, J.3
Chen, C.4
Chen, Y.5
Herzig, M.C.6
Washburn, K.7
Halff, G.A.8
Walter, C.A.9
Sun, B.10
Sun, L.Z.11
-
48
-
-
84859445823
-
TGF-beta in progression of liver disease
-
Dooley S and ten Dijke P. TGF-beta in progression of liver disease. Cell and tissue research. 2012; 347(1):245-256.
-
(2012)
Cell and tissue research.
, vol.347
, Issue.1
, pp. 245-256
-
-
Dooley, S.1
ten Dijke, P.2
-
49
-
-
80755187843
-
Smad phosphoisoform signaling specificity: the right place at the right time
-
Matsuzaki K. Smad phosphoisoform signaling specificity: the right place at the right time. Carcinogenesis. 2011; 32(11):1578-1588.
-
(2011)
Carcinogenesis.
, vol.32
, Issue.11
, pp. 1578-1588
-
-
Matsuzaki, K.1
-
50
-
-
84870518210
-
Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development
-
(Baltimore, Md).
-
Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, Huang L, Han T, Yang W, Wang C, Li Z, Wu MC, Feng GS, Xie WF and Wang HY. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology (Baltimore, Md). 2012; 56(6):2255-2267.
-
(2012)
Hepatology
, vol.56
, Issue.6
, pp. 2255-2267
-
-
Wu, K.1
Ding, J.2
Chen, C.3
Sun, W.4
Ning, B.F.5
Wen, W.6
Huang, L.7
Han, T.8
Yang, W.9
Wang, C.10
Li, Z.11
Wu, M.C.12
Feng, G.S.13
Xie, W.F.14
Wang, H.Y.15
-
51
-
-
75449092617
-
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma
-
Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S and Giannelli G. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology. 2010; 51(2):523-534.
-
(2010)
Hepatology.
, vol.51
, Issue.2
, pp. 523-534
-
-
Mazzocca, A.1
Fransvea, E.2
Dituri, F.3
Lupo, L.4
Antonaci, S.5
Giannelli, G.6
-
52
-
-
78650258154
-
Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma
-
Cano CE, Motoo Y and Iovanna JL. Epithelial-to-mesenchymal transition in pancreatic adenocarcinoma. ScientificWorldJournal. 2010; 10:1947-1957.
-
(2010)
ScientificWorldJournal.
, vol.10
, pp. 1947-1957
-
-
Cano, C.E.1
Motoo, Y.2
Iovanna, J.L.3
-
53
-
-
79551475611
-
TGF-beta1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-kappaB/IL-6/MMP-2
-
Binker MG, Binker-Cosen AA, Gaisano HY, de Cosen RH and Cosen-Binker LI. TGF-beta1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-kappaB/IL-6/MMP-2. Biochemical and biophysical research communications. 2011; 405(1):140-145.
-
(2011)
Biochemical and biophysical research communications.
, vol.405
, Issue.1
, pp. 140-145
-
-
Binker, M.G.1
Binker-Cosen, A.A.2
Gaisano, H.Y.3
de Cosen, R.H.4
Cosen-Binker, L.I.5
-
54
-
-
33746882751
-
Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1
-
Ottaviano AJ, Sun L, Ananthanarayanan V and Munshi HG. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer research. 2006; 66(14):7032-7040.
-
(2006)
Cancer research.
, vol.66
, Issue.14
, pp. 7032-7040
-
-
Ottaviano, A.J.1
Sun, L.2
Ananthanarayanan, V.3
Munshi, H.G.4
-
55
-
-
0035879867
-
TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
-
Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G and Gress TM. TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int J Cancer. 2001; 93(2):204-211.
-
(2001)
Int J Cancer.
, vol.93
, Issue.2
, pp. 204-211
-
-
Ellenrieder, V.1
Hendler, S.F.2
Ruhland, C.3
Boeck, W.4
Adler, G.5
Gress, T.M.6
-
56
-
-
63349088695
-
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma
-
Fransvea E, Mazzocca A, Antonaci S and Giannelli G. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology. 2009; 49(3):839-850.
-
(2009)
Hepatology.
, vol.49
, Issue.3
, pp. 839-850
-
-
Fransvea, E.1
Mazzocca, A.2
Antonaci, S.3
Giannelli, G.4
-
57
-
-
43949140575
-
Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells
-
Fransvea E, Angelotti U, Antonaci S and Giannelli G. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology. 2008; 47(5):1557-1566.
-
(2008)
Hepatology.
, vol.47
, Issue.5
, pp. 1557-1566
-
-
Fransvea, E.1
Angelotti, U.2
Antonaci, S.3
Giannelli, G.4
-
58
-
-
84869050035
-
Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-beta signaling
-
Mima K, Hayashi H, Kuroki H, Nakagawa S, Okabe H, Chikamoto A, Watanabe M, Beppu T and Baba H. Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-beta signaling. Oncology letters. 2013; 5(1):149-154.
-
(2013)
Oncology letters.
, vol.5
, Issue.1
, pp. 149-154
-
-
Mima, K.1
Hayashi, H.2
Kuroki, H.3
Nakagawa, S.4
Okabe, H.5
Chikamoto, A.6
Watanabe, M.7
Beppu, T.8
Baba, H.9
-
59
-
-
84866434918
-
TGF-beta and alphavbeta6 integrin act in a common pathway to suppress pancreatic cancer progression
-
Hezel AF, Deshpande V, Zimmerman SM, Contino G, Alagesan B, O'Dell MR, Rivera LB, Harper J, Lonning S, Brekken RA and Bardeesy N. TGF-beta and alphavbeta6 integrin act in a common pathway to suppress pancreatic cancer progression. Cancer Res. 2012; 72(18):4840-4845.
-
(2012)
Cancer Res.
, vol.72
, Issue.18
, pp. 4840-4845
-
-
Hezel, A.F.1
Deshpande, V.2
Zimmerman, S.M.3
Contino, G.4
Alagesan, B.5
O'Dell, M.R.6
Rivera, L.B.7
Harper, J.8
Lonning, S.9
Brekken, R.A.10
Bardeesy, N.11
-
61
-
-
70349739285
-
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma
-
Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, Watanabe G, Gabriel S, Friedman SL, Kumada H, Llovet JM and Golub TR. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer research. 2009; 69(18):7385-7392.
-
(2009)
Cancer research.
, vol.69
, Issue.18
, pp. 7385-7392
-
-
Hoshida, Y.1
Nijman, S.M.2
Kobayashi, M.3
Chan, J.A.4
Brunet, J.P.5
Chiang, D.Y.6
Villanueva, A.7
Newell, P.8
Ikeda, K.9
Hashimoto, M.10
Watanabe, G.11
Gabriel, S.12
Friedman, S.L.13
Kumada, H.14
Llovet, J.M.15
Golub, T.R.16
-
62
-
-
84866532501
-
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib
-
Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, Villanueva A, Minguez B, Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M, et al. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clinical cancer research: an official journal of the American Association for Cancer Research. 2012; 18(18):4997-5007.
-
(2012)
Clinical cancer research: an official journal of the American Association for Cancer Research.
, vol.18
, Issue.18
, pp. 4997-5007
-
-
Lachenmayer, A.1
Alsinet, C.2
Savic, R.3
Cabellos, L.4
Toffanin, S.5
Hoshida, Y.6
Villanueva, A.7
Minguez, B.8
Newell, P.9
Tsai, H.W.10
Barretina, J.11
Thung, S.12
Ward, S.C.13
Bruix, J.14
Mazzaferro, V.15
Schwartz, M.16
-
63
-
-
47249108568
-
Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic carcinoma cells
-
Romero D, Iglesias M, Vary CP and Quintanilla M. Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic carcinoma cells. Carcinogenesis. 2008; 29(5):1070-1076.
-
(2008)
Carcinogenesis.
, vol.29
, Issue.5
, pp. 1070-1076
-
-
Romero, D.1
Iglesias, M.2
Vary, C.P.3
Quintanilla, M.4
-
64
-
-
84864832834
-
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications
-
Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J and Friess H. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nature reviews Gastroenterology&hepatology. 2012; 9(8):454-467.
-
(2012)
Nature reviews Gastroenterology&hepatology.
, vol.9
, Issue.8
, pp. 454-467
-
-
Erkan, M.1
Hausmann, S.2
Michalski, C.W.3
Fingerle, A.A.4
Dobritz, M.5
Kleeff, J.6
Friess, H.7
-
65
-
-
79955828776
-
Stromal biology and therapy in pancreatic cancer
-
Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM and Tuveson DA. Stromal biology and therapy in pancreatic cancer. Gut. 2011; 60(6):861-868.
-
(2011)
Gut.
, vol.60
, Issue.6
, pp. 861-868
-
-
Neesse, A.1
Michl, P.2
Frese, K.K.3
Feig, C.4
Cook, N.5
Jacobetz, M.A.6
Lolkema, M.P.7
Buchholz, M.8
Olive, K.P.9
Gress, T.M.10
Tuveson, D.A.11
-
66
-
-
20644470124
-
Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas
-
Couvelard A, O'Toole D, Leek R, Turley H, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K and Pezzella F. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology. 2005; 46(6):668-676.
-
(2005)
Histopathology.
, vol.46
, Issue.6
, pp. 668-676
-
-
Couvelard, A.1
O'Toole, D.2
Leek, R.3
Turley, H.4
Sauvanet, A.5
Degott, C.6
Ruszniewski, P.7
Belghiti, J.8
Harris, A.L.9
Gatter, K.10
Pezzella, F.11
-
67
-
-
0038406495
-
Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome
-
Watanabe I, Hasebe T, Sasaki S, Konishi M, Inoue K, Nakagohri T, Oda T, Mukai K and Kinoshita T. Advanced pancreatic ductal cancer: fibrotic focus and beta-catenin expression correlate with outcome. Pancreas. 2003; 26(4):326-333.
-
(2003)
Pancreas.
, vol.26
, Issue.4
, pp. 326-333
-
-
Watanabe, I.1
Hasebe, T.2
Sasaki, S.3
Konishi, M.4
Inoue, K.5
Nakagohri, T.6
Oda, T.7
Mukai, K.8
Kinoshita, T.9
-
68
-
-
84860281544
-
Stroma and pancreatic ductal adenocarcinoma: an interaction loop
-
Luo G, Long J, Zhang B, Liu C, Xu J, Ni Q and Yu X. Stroma and pancreatic ductal adenocarcinoma: an interaction loop. Biochim Biophys Acta. 2012; 1826(1):170-178.
-
(2012)
Biochim Biophys Acta.
, vol.1826
, Issue.1
, pp. 170-178
-
-
Luo, G.1
Long, J.2
Zhang, B.3
Liu, C.4
Xu, J.5
Ni, Q.6
Yu, X.7
-
69
-
-
52149094275
-
The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma
-
Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H and Kleeff J. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol. 2008; 6(10):1155-1161.
-
(2008)
Clin Gastroenterol Hepatol.
, vol.6
, Issue.10
, pp. 1155-1161
-
-
Erkan, M.1
Michalski, C.W.2
Rieder, S.3
Reiser-Erkan, C.4
Abiatari, I.5
Kolb, A.6
Giese, N.A.7
Esposito, I.8
Friess, H.9
Kleeff, J.10
-
70
-
-
4644317795
-
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells
-
Apte MV, Park S, Phillips PA, Santucci N, Goldstein D, Kumar RK, Ramm GA, Buchler M, Friess H, McCarroll JA, Keogh G, Merrett N, Pirola R and Wilson JS. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas. 2004; 29(3):179-187.
-
(2004)
Pancreas.
, vol.29
, Issue.3
, pp. 179-187
-
-
Apte, M.V.1
Park, S.2
Phillips, P.A.3
Santucci, N.4
Goldstein, D.5
Kumar, R.K.6
Ramm, G.A.7
Buchler, M.8
Friess, H.9
McCarroll, J.A.10
Keogh, G.11
Merrett, N.12
Pirola, R.13
Wilson, J.S.14
-
71
-
-
0035863426
-
Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma
-
Lohr M, Schmidt C, Ringel J, Kluth M, Muller P, Nizze H and Jesnowski R. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer research. 2001; 61(2):550-555.
-
(2001)
Cancer research.
, vol.61
, Issue.2
, pp. 550-555
-
-
Lohr, M.1
Schmidt, C.2
Ringel, J.3
Kluth, M.4
Muller, P.5
Nizze, H.6
Jesnowski, R.7
-
72
-
-
17144404527
-
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells
-
Bachem MG, Schunemann M, Ramadani M, Siech M, Beger H, Buck A, Zhou S, Schmid-Kotsas A and Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005; 128(4):907-921.
-
(2005)
Gastroenterology.
, vol.128
, Issue.4
, pp. 907-921
-
-
Bachem, M.G.1
Schunemann, M.2
Ramadani, M.3
Siech, M.4
Beger, H.5
Buck, A.6
Zhou, S.7
Schmid-Kotsas, A.8
Adler, G.9
-
73
-
-
42049097658
-
Pancreatic stellate cells: partners in crime with pancreatic cancer cells
-
Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D and Apte MV. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer research. 2008; 68(7):2085-2093.
-
(2008)
Cancer research.
, vol.68
, Issue.7
, pp. 2085-2093
-
-
Vonlaufen, A.1
Joshi, S.2
Qu, C.3
Phillips, P.A.4
Xu, Z.5
Parker, N.R.6
Toi, C.S.7
Pirola, R.C.8
Wilson, J.S.9
Goldstein, D.10
Apte, M.V.11
-
74
-
-
84866490065
-
Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer
-
Hwang RF, Moore TT, Hattersley MM, Scarpitti M, Yang B, Devereaux E, Ramachandran V, Arumugam T, Ji B, Logsdon CD, Brown JL and Godin R. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Molecular cancer research: MCR. 2012; 10(9):1147-1157.
-
(2012)
Molecular cancer research: MCR.
, vol.10
, Issue.9
, pp. 1147-1157
-
-
Hwang, R.F.1
Moore, T.T.2
Hattersley, M.M.3
Scarpitti, M.4
Yang, B.5
Devereaux, E.6
Ramachandran, V.7
Arumugam, T.8
Ji, B.9
Logsdon, C.D.10
Brown, J.L.11
Godin, R.12
-
75
-
-
84864371568
-
Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice
-
Spector I, Zilberstein Y, Lavy A, Nagler A, Genin O and Pines M. Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice. PLoS One. 2012; 7(7):e41833.
-
(2012)
PLoS One.
, vol.7
, Issue.7
-
-
Spector, I.1
Zilberstein, Y.2
Lavy, A.3
Nagler, A.4
Genin, O.5
Pines, M.6
-
76
-
-
78149315330
-
Role of pancreatic stellate cells in pancreatic cancer metastasis
-
Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer E, Zhang X, Yang L, Biankin AV, Goldstein D, Pirola RC, Wilson JS and Apte MV. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol. 2010; 177(5):2585-2596.
-
(2010)
Am J Pathol.
, vol.177
, Issue.5
, pp. 2585-2596
-
-
Xu, Z.1
Vonlaufen, A.2
Phillips, P.A.3
Fiala-Beer, E.4
Zhang, X.5
Yang, L.6
Biankin, A.V.7
Goldstein, D.8
Pirola, R.C.9
Wilson, J.S.10
Apte, M.V.11
-
77
-
-
84876786403
-
A starring role for stellate cells in the pancreatic cancer microenvironment
-
Apte MV, Wilson JS, Lugea A and Pandol SJ. A starring role for stellate cells in the pancreatic cancer microenvironment. Gastroenterology. 2013; 144(6):1210-1219.
-
(2013)
Gastroenterology.
, vol.144
, Issue.6
, pp. 1210-1219
-
-
Apte, M.V.1
Wilson, J.S.2
Lugea, A.3
Pandol, S.J.4
-
78
-
-
84863082623
-
Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells
-
Apte MV and Wilson JS. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. Journal of gastroenterology and hepatology. 2012; 27 Suppl 2:69-74.
-
(2012)
Journal of gastroenterology and hepatology
, vol.27
, Issue.SUPPL. 2
, pp. 69-74
-
-
Apte, M.V.1
Wilson, J.S.2
-
79
-
-
84872611820
-
Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer
-
Provenzano PP and Hingorani SR. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer. 2013; 108(1):1-8.
-
(2013)
Br J Cancer.
, vol.108
, Issue.1
, pp. 1-8
-
-
Provenzano, P.P.1
Hingorani, S.R.2
-
80
-
-
65949114866
-
Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma
-
Erkan M, Reiser-Erkan C, Michalski CW, Deucker S, Sauliunaite D, Streit S, Esposito I, Friess H and Kleeff J. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia. 2009; 11(5):497-508.
-
(2009)
Neoplasia.
, vol.11
, Issue.5
, pp. 497-508
-
-
Erkan, M.1
Reiser-Erkan, C.2
Michalski, C.W.3
Deucker, S.4
Sauliunaite, D.5
Streit, S.6
Esposito, I.7
Friess, H.8
Kleeff, J.9
-
81
-
-
56449092747
-
Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer
-
Masamune A, Kikuta K, Watanabe T, Satoh K, Hirota M and Shimosegawa T. Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer. American journal of physiology Gastrointestinal and liver physiology. 2008; 295(4):G709-717.
-
(2008)
American journal of physiology Gastrointestinal and liver physiology.
, vol.295
, Issue.4
-
-
Masamune, A.1
Kikuta, K.2
Watanabe, T.3
Satoh, K.4
Hirota, M.5
Shimosegawa, T.6
-
82
-
-
84876408848
-
Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor
-
Eguchi D, Ikenaga N, Ohuchida K, Kozono S, Cui L, Fujiwara K, Fujino M, Ohtsuka T, Mizumoto K and Tanaka M. Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor. The Journal of surgical research. 2013; 181(2):225-233.
-
(2013)
The Journal of surgical research.
, vol.181
, Issue.2
, pp. 225-233
-
-
Eguchi, D.1
Ikenaga, N.2
Ohuchida, K.3
Kozono, S.4
Cui, L.5
Fujiwara, K.6
Fujino, M.7
Ohtsuka, T.8
Mizumoto, K.9
Tanaka, M.10
-
83
-
-
47949099628
-
Modes of resistance to anti-angiogenic therapy
-
Bergers G and Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008; 8(8):592-603.
-
(2008)
Nat Rev Cancer.
, vol.8
, Issue.8
, pp. 592-603
-
-
Bergers, G.1
Hanahan, D.2
-
84
-
-
77955887676
-
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303)
-
Kindler HL, Niedzwiecki D, Hollis D, Sutherland S, Schrag D, Hurwitz H, Innocenti F, Mulcahy MF, O'Reilly E, Wozniak TF, Picus J, Bhargava P, Mayer RJ, Schilsky RL and Goldberg RM. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2010; 28(22):3617-3622.
-
(2010)
Journal of clinical oncology: official journal of the American Society of Clinical Oncology.
, vol.28
, Issue.22
, pp. 3617-3622
-
-
Kindler, H.L.1
Niedzwiecki, D.2
Hollis, D.3
Sutherland, S.4
Schrag, D.5
Hurwitz, H.6
Innocenti, F.7
Mulcahy, M.F.8
O'Reilly, E.9
Wozniak, T.F.10
Picus, J.11
Bhargava, P.12
Mayer, R.J.13
Schilsky, R.L.14
Goldberg, R.M.15
-
85
-
-
84878015534
-
The role of pancreatic stellate cells in pancreatic cancer
-
Erkan M. The role of pancreatic stellate cells in pancreatic cancer. Pancreatology. 2013; 13(2):106-109.
-
(2013)
Pancreatology.
, vol.13
, Issue.2
, pp. 106-109
-
-
Erkan, M.1
-
86
-
-
26644471951
-
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
-
Casanovas O, Hicklin DJ, Bergers G and Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005; 8(4):299-309.
-
(2005)
Cancer Cell.
, vol.8
, Issue.4
, pp. 299-309
-
-
Casanovas, O.1
Hicklin, D.J.2
Bergers, G.3
Hanahan, D.4
-
87
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, Inoue M, Bergers G, Hanahan D and Casanovas O. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009; 15(3):220-231.
-
(2009)
Cancer Cell.
, vol.15
, Issue.3
, pp. 220-231
-
-
Paez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Vinals, F.6
Inoue, M.7
Bergers, G.8
Hanahan, D.9
Casanovas, O.10
-
88
-
-
0037478437
-
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
-
Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S and Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer cell. 2003; 3(4):347-361.
-
(2003)
Cancer cell.
, vol.3
, Issue.4
, pp. 347-361
-
-
Pennacchietti, S.1
Michieli, P.2
Galluzzo, M.3
Mazzone, M.4
Giordano, S.5
Comoglio, P.M.6
-
89
-
-
44449113872
-
Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer
-
Kitajima Y, Ide T, Ohtsuka T and Miyazaki K. Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer science. 2008; 99(7):1341-1347.
-
(2008)
Cancer science.
, vol.99
, Issue.7
, pp. 1341-1347
-
-
Kitajima, Y.1
Ide, T.2
Ohtsuka, T.3
Miyazaki, K.4
-
90
-
-
10744219598
-
Regulation of the chemokine receptor CXCR4 by hypoxia
-
Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G and Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. The Journal of experimental medicine. 2003; 198(9):1391-1402.
-
(2003)
The Journal of experimental medicine.
, vol.198
, Issue.9
, pp. 1391-1402
-
-
Schioppa, T.1
Uranchimeg, B.2
Saccani, A.3
Biswas, S.K.4
Doni, A.5
Rapisarda, A.6
Bernasconi, S.7
Saccani, S.8
Nebuloni, M.9
Vago, L.10
Mantovani, A.11
Melillo, G.12
Sica, A.13
-
91
-
-
0141828145
-
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
-
Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature. 2003; 425(6955):307-311.
-
(2003)
Nature.
, vol.425
, Issue.6955
, pp. 307-311
-
-
Staller, P.1
Sulitkova, J.2
Lisztwan, J.3
Moch, H.4
Oakeley, E.J.5
Krek, W.6
-
92
-
-
79960702572
-
Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells
-
Hashimoto O, Shimizu K, Semba S, Chiba S, Ku Y, Yokozaki H and Hori Y. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells. Pathobiology: journal of immunopathology, molecular and cellular biology. 2011; 78(4):181-192.
-
(2011)
Pathobiology: journal of immunopathology, molecular and cellular biology.
, vol.78
, Issue.4
, pp. 181-192
-
-
Hashimoto, O.1
Shimizu, K.2
Semba, S.3
Chiba, S.4
Ku, Y.5
Yokozaki, H.6
Hori, Y.7
-
93
-
-
84874614138
-
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
-
Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezene P, Dusetti NJ, Loncle C, Calvo E, Turrini O, Iovanna JL, Tomasini R and Vasseur S. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(10):3919-3924.
-
(2013)
Proceedings of the National Academy of Sciences of the United States of America.
, vol.110
, Issue.10
, pp. 3919-3924
-
-
Guillaumond, F.1
Leca, J.2
Olivares, O.3
Lavaut, M.N.4
Vidal, N.5
Berthezene, P.6
Dusetti, N.J.7
Loncle, C.8
Calvo, E.9
Turrini, O.10
Iovanna, J.L.11
Tomasini, R.12
Vasseur, S.13
-
94
-
-
84873160542
-
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
-
Mimeault M and Batra SK. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells. J Cell Mol Med. 2013; 17(1):30-54.
-
(2013)
J Cell Mol Med.
, vol.17
, Issue.1
, pp. 30-54
-
-
Mimeault, M.1
Batra, S.K.2
-
95
-
-
42249099019
-
LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
-
Melisi D, Ishiyama S, Sclabas GM, Fleming JB, Xia Q, Tortora G, Abbruzzese JL and Chiao PJ. LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis. Molecular cancer therapeutics. 2008; 7(4):829-840.
-
(2008)
Molecular cancer therapeutics.
, vol.7
, Issue.4
, pp. 829-840
-
-
Melisi, D.1
Ishiyama, S.2
Sclabas, G.M.3
Fleming, J.B.4
Xia, Q.5
Tortora, G.6
Abbruzzese, J.L.7
Chiao, P.J.8
-
96
-
-
34347216697
-
Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness
-
Gaspar NJ, Li L, Kapoun AM, Medicherla S, Reddy M, Li G, O'Young G, Quon D, Henson M, Damm DL, Muiru GT, Murphy A, Higgins LS, Chakravarty S and Wong DH. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness. Molecular pharmacology. 2007; 72(1):152-161.
-
(2007)
Molecular pharmacology.
, vol.72
, Issue.1
, pp. 152-161
-
-
Gaspar, N.J.1
Li, L.2
Kapoun, A.M.3
Medicherla, S.4
Reddy, M.5
Li, G.6
O'Young, G.7
Quon, D.8
Henson, M.9
Damm, D.L.10
Muiru, G.T.11
Murphy, A.12
Higgins, L.S.13
Chakravarty, S.14
Wong, D.H.15
-
97
-
-
79956217912
-
Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
-
Schlingensiepen KH, Jaschinski F, Lang SA, Moser C, Geissler EK, Schlitt HJ, Kielmanowicz M and Schneider A. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer science. 2011; 102(6):1193-1200.
-
(2011)
Cancer science.
, vol.102
, Issue.6
, pp. 1193-1200
-
-
Schlingensiepen, K.H.1
Jaschinski, F.2
Lang, S.A.3
Moser, C.4
Geissler, E.K.5
Schlitt, H.J.6
Kielmanowicz, M.7
Schneider, A.8
-
98
-
-
84995268963
-
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
-
European Association for Study of L, European Organisation for R and Treatment of C
-
European Association for Study of L, European Organisation for R and Treatment of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. European journal of cancer. 2012; 48(5):599-641.
-
(2012)
European journal of cancer.
, vol.48
, Issue.5
, pp. 599-641
-
-
-
99
-
-
84875739145
-
Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results
-
Frampas E, Lassau N, Zappa M, Vullierme MP, Koscielny S and Vilgrain V. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. European journal of radiology. 2013; 82(5):e205-211.
-
(2013)
European journal of radiology.
, vol.82
, Issue.5
-
-
Frampas, E.1
Lassau, N.2
Zappa, M.3
Vullierme, M.P.4
Koscielny, S.5
Vilgrain, V.6
-
100
-
-
61949171989
-
Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia
-
International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular N.
-
International Consensus Group for Hepatocellular NeoplasiaThe International Consensus Group for Hepatocellular N. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology. 2009; 49(2):658-664.
-
(2009)
Hepatology.
, vol.49
, Issue.2
, pp. 658-664
-
-
-
101
-
-
4043169060
-
Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma
-
Messerini L, Novelli L and Comin CE. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma. Journal of clinical pathology. 2004; 57(8):867-871.
-
(2004)
Journal of clinical pathology.
, vol.57
, Issue.8
, pp. 867-871
-
-
Messerini, L.1
Novelli, L.2
Comin, C.E.3
-
102
-
-
79960590467
-
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib
-
Harmon CS, DePrimo SE, Raymond E, Cheng AL, Boucher E, Douillard JY, Lim HY, Kim JS, Lechuga MJ, Lanzalone S, Lin X and Faivre S. Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. Journal of translational medicine. 2011; 9:120.
-
(2011)
Journal of translational medicine.
, vol.9
, pp. 120
-
-
Harmon, C.S.1
DePrimo, S.E.2
Raymond, E.3
Cheng, A.L.4
Boucher, E.5
Douillard, J.Y.6
Lim, H.Y.7
Kim, J.S.8
Lechuga, M.J.9
Lanzalone, S.10
Lin, X.11
Faivre, S.12
-
103
-
-
35448991324
-
Extracellular control of TGFbeta signalling in vascular development and disease
-
ten Dijke P and Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nature reviews Molecular cell biology. 2007; 8(11):857-869.
-
(2007)
Nature reviews Molecular cell biology.
, vol.8
, Issue.11
, pp. 857-869
-
-
ten Dijke, P.1
Arthur, H.M.2
-
104
-
-
0028952342
-
Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma
-
Ito N, Kawata S, Tamura S, Shirai Y, Kiso S, Tsushima H and Matsuzawa Y. Positive correlation of plasma transforming growth factor-beta 1 levels with tumor vascularity in hepatocellular carcinoma. Cancer letters. 1995; 89(1):45-48.
-
(1995)
Cancer letters.
, vol.89
, Issue.1
, pp. 45-48
-
-
Ito, N.1
Kawata, S.2
Tamura, S.3
Shirai, Y.4
Kiso, S.5
Tsushima, H.6
Matsuzawa, Y.7
-
105
-
-
0035914297
-
Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression
-
Sanchez-Elsner T, Botella LM, Velasco B, Corbi A, Attisano L and Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. The Journal of biological chemistry. 2001; 276(42):38527-38535.
-
(2001)
The Journal of biological chemistry.
, vol.276
, Issue.42
, pp. 38527-38535
-
-
Sanchez-Elsner, T.1
Botella, L.M.2
Velasco, B.3
Corbi, A.4
Attisano, L.5
Bernabeu, C.6
-
106
-
-
70350059078
-
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation
-
Mazzocca A, Fransvea E, Lavezzari G, Antonaci S and Giannelli G. Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation. Hepatology. 2009; 50(4):1140-1151.
-
(2009)
Hepatology.
, vol.50
, Issue.4
, pp. 1140-1151
-
-
Mazzocca, A.1
Fransvea, E.2
Lavezzari, G.3
Antonaci, S.4
Giannelli, G.5
-
107
-
-
0029878808
-
Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis
-
Murawaki Y, Ikuta Y, Nishimura Y, Koda M and Kawasaki H. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. Journal of gastroenterology and hepatology. 1996; 11(5):443-450.
-
(1996)
Journal of gastroenterology and hepatology.
, vol.11
, Issue.5
, pp. 443-450
-
-
Murawaki, Y.1
Ikuta, Y.2
Nishimura, Y.3
Koda, M.4
Kawasaki, H.5
-
108
-
-
0038353468
-
Reversal of tumor-induced immunosuppression by TGF-beta inhibitors
-
Wojtowicz-Praga S. Reversal of tumor-induced immunosuppression by TGF-beta inhibitors. Invest New Drugs. 2003; 21(1):21-32.
-
(2003)
Invest New Drugs.
, vol.21
, Issue.1
, pp. 21-32
-
-
Wojtowicz-Praga, S.1
-
109
-
-
77954557286
-
TGFbeta and cancer metastasis: an inflammation link
-
Yang L. TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev. 2010; 29(2):263-271.
-
(2010)
Cancer Metastasis Rev.
, vol.29
, Issue.2
, pp. 263-271
-
-
Yang, L.1
-
110
-
-
0028982242
-
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders
-
Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh CG, Gress RE and Karlsson S. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am J Pathol. 1995; 146(1):264-275.
-
(1995)
Am J Pathol.
, vol.146
, Issue.1
, pp. 264-275
-
-
Kulkarni, A.B.1
Ward, J.M.2
Yaswen, L.3
Mackall, C.L.4
Bauer, S.R.5
Huh, C.G.6
Gress, R.E.7
Karlsson, S.8
-
111
-
-
0026799402
-
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease
-
Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D and et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992; 359(6397):693-699.
-
(1992)
Nature.
, vol.359
, Issue.6397
, pp. 693-699
-
-
Shull, M.M.1
Ormsby, I.2
Kier, A.B.3
Pawlowski, S.4
Diebold, R.J.5
Yin, M.6
Allen, R.7
Sidman, C.8
Proetzel, G.9
Calvin, D.10
-
112
-
-
0035291879
-
Systemic and local immunosuppression in pancreatic cancer patients
-
von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, Johnk C, Henne-Bruns D, Kremer B and Kalthoff H. Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res. 2001; 7(3 Suppl):925s-932s.
-
(2001)
Clin Cancer Res
, vol.7
, Issue.3 SUPPL.
-
-
von Bernstorff, W.1
Voss, M.2
Freichel, S.3
Schmid, A.4
Vogel, I.5
Johnk, C.6
Henne-Bruns, D.7
Kremer, B.8
Kalthoff, H.9
-
113
-
-
35348901453
-
Basics of TGF-beta and pancreatic cancer
-
Truty MJ and Urrutia R. Basics of TGF-beta and pancreatic cancer. Pancreatology. 2007; 7(5-6):423-435.
-
(2007)
Pancreatology.
, vol.7
, Issue.5-6
, pp. 423-435
-
-
Truty, M.J.1
Urrutia, R.2
-
114
-
-
80053609350
-
Transforming growth factor-beta in the gastrointestinal and hepatic tumor microenvironment
-
Achyut BR and Yang L. Transforming growth factor-beta in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology. 2011; 141(4):1167-1178.
-
(2011)
Gastroenterology.
, vol.141
, Issue.4
, pp. 1167-1178
-
-
Achyut, B.R.1
Yang, L.2
-
115
-
-
77953023274
-
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
-
Yang L, Pang Y and Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends in immunology. 2010; 31(6):220-227.
-
(2010)
Trends in immunology.
, vol.31
, Issue.6
, pp. 220-227
-
-
Yang, L.1
Pang, Y.2
Moses, H.L.3
-
116
-
-
84893864016
-
Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen
-
Helmut Oettle TS, Thomas Luger, Roland M. Schmid, Goetz von Wichert, Esther Endlicher, Claus Garbe, Katharina K. Kaehler, Alexander Enk, Anneliese Schneider, Tanja Rothhammer-Hampl, Susanne Grosser, Peter Kiessling. (2012). Final results of a phase I/II study in patients with pancreatic cancer, malignant melanoma, and colorectal carcinoma with trabedersen. ASCO: Journal of clinical oncology).
-
(2012)
ASCO: Journal of clinical oncology
-
-
Helmut Oettle, T.S.1
Luger, T.2
Roland Schmid, M.3
von Wichert, G.4
Endlicher, E.5
Garbe, C.6
Katharina Kaehler, K.7
Enk, A.8
Schneider, A.9
Rothhammer-Hampl, T.10
Grosser, S.11
Kiessling, P.12
-
117
-
-
33750586798
-
Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer
-
Nemunaitis J, Dillman RO, Schwarzenberger PO, Senzer N, Cunningham C, Cutler J, Tong A, Kumar P, Pappen B, Hamilton C, DeVol E, Maples PB, Liu L, Chamberlin T, Shawler DL and Fakhrai H. Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2006; 24(29):4721-4730.
-
(2006)
Journal of clinical oncology: official journal of the American Society of Clinical Oncology.
, vol.24
, Issue.29
, pp. 4721-4730
-
-
Nemunaitis, J.1
Dillman, R.O.2
Schwarzenberger, P.O.3
Senzer, N.4
Cunningham, C.5
Cutler, J.6
Tong, A.7
Kumar, P.8
Pappen, B.9
Hamilton, C.10
DeVol, E.11
Maples, P.B.12
Liu, L.13
Chamberlin, T.14
Shawler, D.L.15
Fakhrai, H.16
-
118
-
-
84872414706
-
Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFbeta1-targeting peptides P17 and P144
-
Zubeldia IG, Bleau AM, Redrado M, Serrano D, Agliano A, Gil-Puig C, Vidal-Vanaclocha F, Lecanda J and Calvo A. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFbeta1-targeting peptides P17 and P144. Experimental cell research. 2013; 319(3):12-22.
-
(2013)
Experimental cell research.
, vol.319
, Issue.3
, pp. 12-22
-
-
Zubeldia, I.G.1
Bleau, A.M.2
Redrado, M.3
Serrano, D.4
Agliano, A.5
Gil-Puig, C.6
Vidal-Vanaclocha, F.7
Lecanda, J.8
Calvo, A.9
-
119
-
-
84879528782
-
Differential Inhibition of the TGF-beta Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-beta Receptor Type II
-
Dituri F, Mazzocca A, Peidro FJ, Papappicco P, Fabregat I, De Santis F, Paradiso A, Sabba C and Giannelli G. Differential Inhibition of the TGF-beta Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-beta Receptor Type II. PloS one. 2013; 8(6):e67109.
-
(2013)
PloS one.
, vol.8
, Issue.6
-
-
Dituri, F.1
Mazzocca, A.2
Peidro, F.J.3
Papappicco, P.4
Fabregat, I.5
De Santis, F.6
Paradiso, A.7
Sabba, C.8
Giannelli, G.9
-
120
-
-
84874607100
-
TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer
-
Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, Sanders M, Stanford J, Cook RS and Arteaga CL. TGF-beta inhibition enhances chemotherapy action against triple-negative breast cancer. The Journal of clinical investigation. 2013; 123(3):1348-1358.
-
(2013)
The Journal of clinical investigation.
, vol.123
, Issue.3
, pp. 1348-1358
-
-
Bhola, N.E.1
Balko, J.M.2
Dugger, T.C.3
Kuba, M.G.4
Sanchez, V.5
Sanders, M.6
Stanford, J.7
Cook, R.S.8
Arteaga, C.L.9
-
121
-
-
84893827556
-
Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC)
-
Sandrine J. Faivre AS, Robin Katie Kelley, Philippe Merle, Ed Gane, Jean-Yves Douillard, Dirk Waldschmidt, Mary Frances Mulcahy, Charlotte Costentin, Beatriz Minguez, Pasqua Papappicco, Ivelina Gueorguieva, Ann Cleverly, Durisala Desaiah, Michael M. F. Lahn, Nicola Murray, Karim A. Benhadji, Eric Raymond, Gianluigi Giannelli. (2013). Randomized dose comparison phase II study of the oral transforming growth factor-beta (TGF-ß) receptor I kinase inhibitor LY2157299 monohydrate (LY) in patients with advanced hepatocellular carcinoma (HCC). Journal of clinical oncology).
-
(2013)
Journal of clinical oncology)
-
-
Sandrine, J.1
Faivre, A.S.2
Kelley, R.K.3
Merle, P.4
Gane, E.5
Douillard, J.-Y.6
Waldschmidt, D.7
Mulcahy, M.F.8
Costentin, C.9
Minguez, B.10
Papappicco, P.11
Gueorguieva, I.12
Cleverly, A.13
Desaiah, D.14
Michael Lahn, M.F.15
Murray, N.16
Karim Benhadji, A.17
Raymond, E.18
Giannelli, G.19
-
122
-
-
0035941075
-
Taking cell-matrix adhesions to the third dimension
-
Cukierman E, Pankov R, Stevens DR and Yamada KM. Taking cell-matrix adhesions to the third dimension. Science. 2001; 294(5547):1708-1712.
-
(2001)
Science.
, vol.294
, Issue.5547
, pp. 1708-1712
-
-
Cukierman, E.1
Pankov, R.2
Stevens, D.R.3
Yamada, K.M.4
-
123
-
-
34547931078
-
Modeling tissue morphogenesis and cancer in 3D
-
Yamada KM and Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell. 2007; 130(4):601-610.
-
(2007)
Cell.
, vol.130
, Issue.4
, pp. 601-610
-
-
Yamada, K.M.1
Cukierman, E.2
-
124
-
-
67650999336
-
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis
-
Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Muller A, Tuschl G, Mueller SO and Dooley S. Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis. Hepatology. 2009; 49(6):2031-2043.
-
(2009)
Hepatology.
, vol.49
, Issue.6
, pp. 2031-2043
-
-
Godoy, P.1
Hengstler, J.G.2
Ilkavets, I.3
Meyer, C.4
Bachmann, A.5
Muller, A.6
Tuschl, G.7
Mueller, S.O.8
Dooley, S.9
-
125
-
-
79961226547
-
A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFbeta in pancreatic cancer cells
-
Sempere LF, Gunn JR and Korc M. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFbeta in pancreatic cancer cells. Cancer Biol Ther. 2011; 12(3):198-207.
-
(2011)
Cancer Biol Ther.
, vol.12
, Issue.3
, pp. 198-207
-
-
Sempere, L.F.1
Gunn, J.R.2
Korc, M.3
-
127
-
-
34248185926
-
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
-
Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, Moses HL, Freeman ML and Arteaga CL. Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest. 2007; 117(5):1305-1313.
-
(2007)
J Clin Invest.
, vol.117
, Issue.5
, pp. 1305-1313
-
-
Biswas, S.1
Guix, M.2
Rinehart, C.3
Dugger, T.C.4
Chytil, A.5
Moses, H.L.6
Freeman, M.L.7
Arteaga, C.L.8
-
128
-
-
39149089610
-
Defective TGF-beta signaling sensitizes human cancer cells to rapamycin
-
Gadir N, Jackson DN, Lee E and Foster DA. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin. Oncogene. 2008; 27(8):1055-1062.
-
(2008)
Oncogene.
, vol.27
, Issue.8
, pp. 1055-1062
-
-
Gadir, N.1
Jackson, D.N.2
Lee, E.3
Foster, D.A.4
-
129
-
-
84859412054
-
Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212
-
Jing J, Greshock J, Holbrook JD, Gilmartin A, Zhang X, McNeil E, Conway T, Moy C, Laquerre S, Bachman K, Wooster R and Degenhardt Y. Comprehensive predictive biomarker analysis for MEK inhibitor GSK1120212. Mol Cancer Ther. 2012; 11(3):720-729.
-
(2012)
Mol Cancer Ther.
, vol.11
, Issue.3
, pp. 720-729
-
-
Jing, J.1
Greshock, J.2
Holbrook, J.D.3
Gilmartin, A.4
Zhang, X.5
McNeil, E.6
Conway, T.7
Moy, C.8
Laquerre, S.9
Bachman, K.10
Wooster, R.11
Degenhardt, Y.12
-
130
-
-
77954372059
-
Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms
-
Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver international: official journal of the International Association for the Study of the Liver. 2010; 30(5):669-682.
-
(2010)
Liver international: official journal of the International Association for the Study of the Liver.
, vol.30
, Issue.5
, pp. 669-682
-
-
Copple, B.L.1
-
131
-
-
0031842971
-
Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture
-
Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, Korsten MA, Pirola RC and Wilson JS. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut. 1998; 43(1):128-133.
-
(1998)
Gut.
, vol.43
, Issue.1
, pp. 128-133
-
-
Apte, M.V.1
Haber, P.S.2
Applegate, T.L.3
Norton, I.D.4
McCaughan, G.W.5
Korsten, M.A.6
Pirola, R.C.7
Wilson, J.S.8
-
132
-
-
78651385353
-
Pancreatic cancer: the role of pancreatic stellate cells in tumor progression
-
Duner S, Lopatko Lindman J, Ansari D, Gundewar C and Andersson R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology. 2010; 10(6):673-681.
-
(2010)
Pancreatology.
, vol.10
, Issue.6
, pp. 673-681
-
-
Duner, S.1
Lopatko Lindman, J.2
Ansari, D.3
Gundewar, C.4
Andersson, R.5
-
133
-
-
13644267274
-
Molecular regulation of pancreatic stellate cell function
-
Jaster R. Molecular regulation of pancreatic stellate cell function. Mol Cancer. 2004; 3:26.
-
(2004)
Mol Cancer.
, vol.3
, pp. 26
-
-
Jaster, R.1
-
135
-
-
10744225478
-
Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions
-
Ohnishi H, Miyata T, Yasuda H, Satoh Y, Hanatsuka K, Kita H, Ohashi A, Tamada K, Makita N, Iiri T, Ueda N, Mashima H and Sugano K. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions. J Biol Chem. 2004; 279(10):8873-8878.
-
(2004)
J Biol Chem.
, vol.279
, Issue.10
, pp. 8873-8878
-
-
Ohnishi, H.1
Miyata, T.2
Yasuda, H.3
Satoh, Y.4
Hanatsuka, K.5
Kita, H.6
Ohashi, A.7
Tamada, K.8
Makita, N.9
Iiri, T.10
Ueda, N.11
Mashima, H.12
Sugano, K.13
-
136
-
-
79960727727
-
Hepatic stellate cells: partners in crime for liver metastases?
-
Kang N, Gores GJ and Shah VH. Hepatic stellate cells: partners in crime for liver metastases? Hepatology. 2011; 54(2):707-713.
-
(2011)
Hepatology.
, vol.54
, Issue.2
, pp. 707-713
-
-
Kang, N.1
Gores, G.J.2
Shah, V.H.3
-
137
-
-
54249088477
-
Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance
-
Vonlaufen A, Phillips PA, Xu Z, Goldstein D, Pirola RC, Wilson JS and Apte MV. Pancreatic stellate cells and pancreatic cancer cells: an unholy alliance. Cancer research. 2008; 68(19):7707-7710.
-
(2008)
Cancer research.
, vol.68
, Issue.19
, pp. 7707-7710
-
-
Vonlaufen, A.1
Phillips, P.A.2
Xu, Z.3
Goldstein, D.4
Pirola, R.C.5
Wilson, J.S.6
Apte, M.V.7
-
138
-
-
0022373618
-
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells
-
Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB and Goeddel DV. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 1985; 316(6030):701-705.
-
(1985)
Nature.
, vol.316
, Issue.6030
, pp. 701-705
-
-
Derynck, R.1
Jarrett, J.A.2
Chen, E.Y.3
Eaton, D.H.4
Bell, J.R.5
Assoian, R.K.6
Roberts, A.B.7
Sporn, M.B.8
Goeddel, D.V.9
-
139
-
-
0034678908
-
Transcriptional control by the TGF-beta/Smad signaling system
-
Massague J and Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. The EMBO journal. 2000; 19(8):1745-1754.
-
(2000)
The EMBO journal.
, vol.19
, Issue.8
, pp. 1745-1754
-
-
Massague, J.1
Wotton, D.2
-
141
-
-
0036670339
-
Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity
-
Inman GJ, Nicolas FJ and Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Molecular cell. 2002; 10(2):283-294.
-
(2002)
Molecular cell.
, vol.10
, Issue.2
, pp. 283-294
-
-
Inman, G.J.1
Nicolas, F.J.2
Hill, C.S.3
-
142
-
-
0142104985
-
Smad-dependent and Smad-independent pathways in TGF-beta family signalling
-
Derynck R and Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425(6958):577-584.
-
(2003)
Nature.
, vol.425
, Issue.6958
, pp. 577-584
-
-
Derynck, R.1
Zhang, Y.E.2
-
143
-
-
33745515023
-
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer
-
Bierie B and Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nature reviews Cancer. 2006; 6(7):506-520.
-
(2006)
Nature reviews Cancer.
, vol.6
, Issue.7
, pp. 506-520
-
-
Bierie, B.1
Moses, H.L.2
|